Professional Seasonal Analysis for Trading

Protagonist Therapeutics, Inc. - Common Stock (PTGX)

Seasonality Analysis

Stocks 10 Years Analyzed

Protagonist Therapeutics, Inc. - Common Stock Annual Seasonality Statistics

55.03%
Avg Annual Return
57.6%
Avg Monthly Win Rate
10/12
Positive Months
10
Years Analyzed

Protagonist Therapeutics, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 3.00%
60%
Moderate
February -2.77%
50%
Weak
March 3.67%
40%
Weak
April WORST -8.92%
40%
Weak
May BEST 19.48%
67%
Strong
June 8.73%
78%
Very Strong
July 2.17%
67%
Strong
August 15.06%
80%
Very Strong
September 0.03%
50%
Weak
October 3.77%
40%
Weak
November 7.11%
60%
Moderate
December 3.71%
60%
Moderate

Protagonist Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
100
Historical Avg Position
29.96
Deviation
+70.04
Performance
Significantly Above Average

Protagonist Therapeutics, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for PTGX with overlay patterns, custom date ranges, and more.

Create Free Account

Protagonist Therapeutics, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Protagonist Therapeutics, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for PTGX across multiple timeframes.

Create Free Account

About Protagonist Therapeutics, Inc. - Common Stock (PTGX) Seasonality

Protagonist Therapeutics, Inc. - Common Stock (PTGX) has been analyzed using 10 years of historical data to identify seasonal patterns. Classified under Stocks, Protagonist Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Protagonist Therapeutics, Inc. - Common Stock is historically May, with an average return of 19.48% and a win rate of 67%. Conversely, April tends to be the weakest month, averaging -8.92% return.

Looking at the full calendar year, Protagonist Therapeutics, Inc. - Common Stock has an average annual return of 55.03% with an overall monthly win rate of 57.6%. Out of 12 months, 10 typically show positive average returns.

The seasonal pattern for Protagonist Therapeutics, Inc. - Common Stock has a consistency score of 25.8 (Poor), based on 11 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Protagonist Therapeutics, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Protagonist Therapeutics, Inc. - Common Stock (PTGX)?

Historically, May has been the best month for Protagonist Therapeutics, Inc. - Common Stock, with an average return of 19.48% and a win rate of 67%. However, past performance does not guarantee future results.

What is the worst month for Protagonist Therapeutics, Inc. - Common Stock (PTGX)?

Based on historical data, April has been the weakest month for Protagonist Therapeutics, Inc. - Common Stock, with an average return of -8.92%. This is a historical observation and does not guarantee future results.

How reliable is PTGX seasonality data?

The seasonality analysis for Protagonist Therapeutics, Inc. - Common Stock is based on 10 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Protagonist Therapeutics, Inc. - Common Stock seasonality in my trading?

Use Protagonist Therapeutics, Inc. - Common Stock (PTGX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.